European Commission Approves Influenza A(H1N1) Vaccine
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




European Commission Approves Influenza A(H1N1) Vaccine

NEW YORK -- October 07, 2009 -- The European Commission (EC) has granted marketing authorisation for a cell culture-based non-adjuvanted influenza A(H1N1) vaccine (CELVAPAN).

The vaccine have already been received by a number of countries, including the United Kingdom and Ireland, for use in their national vaccination programs.

The safety and immunogenicity of the vaccines is being confirmed in clinical trials and will supplement the licensure post-approval with data from its ongoing clinical trial program.

Preliminary safety data from ongoing clinical trials in adults aged 18 years and older indicate the vaccine is well tolerated. The observed systemic and local reactions are similar to those generally experienced after vaccination with licensed seasonal influenza vaccines.

Immunogenicity data from the first vaccination in adults will be submitted to the European Medicines Agency within days.

The 2 randomised, ongoing trials include 400 healthy adults aged 18 years and over and 400 children and adolescents. The trials are evaluating the safety and immunogenicity of the vaccine at dose levels of 7.5 mcg and 3.75 mcg. A large-scale observational study will also be conducted 9,000 people of different age groups, including children.

SOURCE: Baxter International Inc.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities